78 related articles for article (PubMed ID: 8261413)
21. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
[TBL] [Abstract][Full Text] [Related]
22. Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment.
Dong D; Ko B; Baumeister P; Swenson S; Costa F; Markland F; Stiles C; Patterson JB; Bates SE; Lee AS
Cancer Res; 2005 Jul; 65(13):5785-91. PubMed ID: 15994954
[TBL] [Abstract][Full Text] [Related]
23. GRP78 and Raf-1 cooperatively confer resistance to endoplasmic reticulum stress-induced apoptosis.
Shu CW; Sun FC; Cho JH; Lin CC; Liu PF; Chen PY; Chang MD; Fu HW; Lai YK
J Cell Physiol; 2008 Jun; 215(3):627-35. PubMed ID: 18064632
[TBL] [Abstract][Full Text] [Related]
24. Expression of stress response protein glucose regulated protein-78 mediated by c-Myb.
Ramsay RG; Ciznadija D; Mantamadiotis T; Anderson R; Pearson R
Int J Biochem Cell Biol; 2005 Jun; 37(6):1254-68. PubMed ID: 15778089
[TBL] [Abstract][Full Text] [Related]
25. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
[TBL] [Abstract][Full Text] [Related]
26. Rapid induction of CD95 ligand and CD4+ T cell-mediated apoptosis by CD137 (4-1BB) costimulation.
Ebata T; Mogi S; Hata Y; Fujimoto JI; Yagita H; Okumura K; Azuma M
Eur J Immunol; 2001 May; 31(5):1410-6. PubMed ID: 11465097
[TBL] [Abstract][Full Text] [Related]
27. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
28. Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model.
Fernando GJ; Stewart TJ; Tindle RW; Frazer IH
J Immunol; 1998 Sep; 161(5):2421-7. PubMed ID: 9725239
[TBL] [Abstract][Full Text] [Related]
29. IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms.
Smith DJ; McGuire MJ; Tocci MJ; Thiele DL
J Immunol; 1997 Jan; 158(1):163-70. PubMed ID: 8977187
[TBL] [Abstract][Full Text] [Related]
30. Okadaic acid as an inducer of the 78-kDa glucose-regulated protein in 9L rat brain tumor cells.
Hou MC; Shen CH; Lee WC; Lai YK
J Cell Biochem; 1993 Jan; 51(1):91-101. PubMed ID: 8381791
[TBL] [Abstract][Full Text] [Related]
31. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
Giovarelli M; Musiani P; Garotta G; Ebner R; Di Carlo E; Kim Y; Cappello P; Rigamonti L; Bernabei P; Novelli F; Modesti A; Coletti A; Ferrie AK; Lollini PL; Ruben S; Salcedo T; Forni G
J Immunol; 1999 Nov; 163(9):4886-93. PubMed ID: 10528190
[TBL] [Abstract][Full Text] [Related]
32. A role for heat shock protein 27 in CTL-mediated cell death.
Beresford PJ; Jaju M; Friedman RS; Yoon MJ; Lieberman J
J Immunol; 1998 Jul; 161(1):161-7. PubMed ID: 9647220
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of the endoplasmic reticulum chaperone GRP78/BiP by vomitoxin (Deoxynivalenol).
Yang GH; Li S; Pestka JJ
Toxicol Appl Pharmacol; 2000 Feb; 162(3):207-17. PubMed ID: 10652249
[TBL] [Abstract][Full Text] [Related]
34. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
35. Decreased protein and mRNA expression of ER stress proteins GRP78 and GRP94 in HepG2 cells over-expressing CYP2E1.
Dey A; Kessova IG; Cederbaum AI
Arch Biochem Biophys; 2006 Mar; 447(2):155-66. PubMed ID: 16497268
[TBL] [Abstract][Full Text] [Related]
36. The role of TNF-TNFR2 interactions in generation of CTL responses and clearance of hepatic adenovirus infection.
Kafrouni MI; Brown GR; Thiele DL
J Leukoc Biol; 2003 Oct; 74(4):564-71. PubMed ID: 12960267
[TBL] [Abstract][Full Text] [Related]
37. Requirements for CD28-dependent T cell-mediated cytotoxicity.
Azuma M; Cayabyab M; Phillips JH; Lanier LL
J Immunol; 1993 Mar; 150(6):2091-101. PubMed ID: 8383716
[TBL] [Abstract][Full Text] [Related]
38. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
Williams NS; Engelhard VH
J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
[TBL] [Abstract][Full Text] [Related]
39. Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line.
Mese H; Sasaki A; Nakayama S; Yokoyama S; Sawada S; Ishikawa T; Matsumura T
Anticancer Res; 2001; 21(2A):1029-33. PubMed ID: 11396136
[TBL] [Abstract][Full Text] [Related]
40. Polychlorinated biphenyl-induced immune suppression: castration, but not adrenalectomy or RU 38486 treatment, partially restores the suppressed cytotoxic T lymphocyte response to alloantigen.
De Krey GK; Baecher-Steppan L; Deyo JA; Smith B; Kerkvliet NI
J Pharmacol Exp Ther; 1993 Oct; 267(1):308-15. PubMed ID: 8229756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]